Equitec Proprietary Markets, LLC Alaunos Therapeutics, Inc. Put Options Transaction History

Equitec Proprietary Markets, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Jul 20, 2021	SELL	$2.63 - $3.67 $7,890 - $11,010	-3,000 Reduced 12.4%	21,200 $56,000
Q1 2020 Apr 19, 2021	BUY	$1.9 - $4.98 $26,980 - $70,716	14,200 Added 142.0%	24,200 $87,000
Q2 2018 Jul 17, 2018	SELL	$3.02 - $4.94 $27,180 - $44,460	-9,000 Reduced 47.37%	10,000 $30,000
Q1 2018 May 23, 2018	SELL	$3.46 - $5.14 $139,784 - $207,656	-40,400 Reduced 68.01%	19,000 $74,000
Q4 2017 Jan 24, 2018	BUY	$4.0 - $6.54 $50,800 - $83,058	12,700 Added 27.19%	59,400 $246,000
Q3 2017 Oct 23, 2017	BUY	$4.99 - $6.57 $233,033 - $306,819	46,700	46,700 $287,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.